Skip to main content
. 2014 Jul 31;28(5):349–359. doi: 10.7555/JBR.28.20140045

Table 4. Baseline characteristics of heart failure patient cohorts.

Heart failure patients HFGR LEITZARAN HULL LIFELAB TIME-CHF
Number of patients 218 233 3239 622
Women, No. (%) 59 (27) 109 (46) 1068 (33) 253 (40.7)
Age, years 67±13 74±9 71±11 77±8
Body mass index, kg/m2 28.7±5.6 31.3±5.3 29.2±6.0 25.6±4.4
Weight, kg 82.6±19.2 79.4±16.3 82.4±19.3 72.0±14.2
Height, cm 171±10 159±10 168±10 167±9
Smokers, No. (%) NA NA 300 (9) 74 (12)
Consume alcohol, No. (%) NA 18 (8) 1179 (36) NA
Hypertension, No. (%) 92 (42) 233 (100) 1115 (35) 462 (74)
Diabetes mellitus, No. (%) 75 (34) 0 (0) 784 (24) 222 (36)
Heart failure, No. (%) 218 (100) 233 (100) 2306 (71) 622 (100)
Systolic blood pressure, mmHg 121±22 148±24 137±25 122±20
Diastolic blood pressure, mmHg 68±11 85±13 79±14 72±12
Heart rate, beats per minute 72±14 79±20 74±17 76±14
Cholesterol, mmol/L 4.0±1.2 5.2±1.8 4.4±1.3 4.2±1.1
Glucose, mmol/L 8.0±3.3 6.0±1.7 6.8±2.9 6.7±2.4
Hemoglobin, g/dL 13.0±1.9 14.0±1.5 13.3±3.7 13.1±1.8
Red blood cell count, 1012 cells/L NA 4.6±0.47 NA 4.3±0.60
White blood cell count, 109 cells/L 7.7±2.7 7.0±1.8 7.6±2.8 7.8±4.9
Platelets, 109 cells/L 223±71 223±58 242±95 NA
Creatinine, μmol/L 111.2±34.8 96.4±33.8 105.7±50.6 115.9±38.4
BNP, pg/mL NA NA NA NA
NT-proBNP, pg/mL NA NA 880 (279–2088) 3836 (1919–6895)
Left ventricular mass, g NA 270.6±115.8 271.6±116.0 NA
Left ventricular ejection fraction, % 35±12 55±16 41±14 35±13
Proportion with LVEF <40% 70 (65) 24 (17) 880 (51) 402 (65)
Proportion with LVEF 40–50% 20 (19) 21 (15) 360 (21) 108 (17)
Proportion with LVEF >50% 17 (16) 96 (68) 481 (28) 112 (18)
E/A ratio NA 0.90±0.46 1.1±0.85 NA

Data are reported as number (%), mean±SD or median (25th–75th) for non-normally distributed data.

NA: data not available within the cohort